Sonoma Pharmaceuticals, Inc. (SNOA)

USD 2.45

(6.99%)

Long Term Debt Summary of Sonoma Pharmaceuticals, Inc.

  • Sonoma Pharmaceuticals, Inc.'s latest annual long term debt in 2024 was 87 Thousand USD , down 0.0% from previous year.
  • Sonoma Pharmaceuticals, Inc.'s latest quarterly long term debt in 2024 FY was 87 Thousand USD , down -46.3% from previous quarter.
  • Sonoma Pharmaceuticals, Inc. reported annual long term debt of 162 Thousand USD in 2023, down -47.57% from previous year.
  • Sonoma Pharmaceuticals, Inc. reported annual long term debt of 309 Thousand USD in 2022, down -83.2% from previous year.
  • Sonoma Pharmaceuticals, Inc. reported quarterly long term debt of 160 Thousand USD for 2024 Q3, down 0.0% from previous quarter.
  • Sonoma Pharmaceuticals, Inc. reported quarterly long term debt of 87 Thousand USD for 2024 Q4, down 0.0% from previous quarter.

Annual Long Term Debt Chart of Sonoma Pharmaceuticals, Inc. (2024 - 2002)

Created with Highcharts 11.1.0YearsLong Term Debt2002200420062008201020122014201620182020202220240 USD500000 USD1000000 USD1500000 USD2000000 USD2500000 USD

Historical Annual Long Term Debt of Sonoma Pharmaceuticals, Inc. (2024 - 2002)

Year Long Term Debt Long Term Debt Growth
2024 87 Thousand USD 0.0%
2023 162 Thousand USD -47.57%
2022 309 Thousand USD -83.2%
2021 1.83 Million USD 146.51%
2020 746 Thousand USD 6116.67%
2019 12 Thousand USD -93.18%
2018 176 Thousand USD -17.37%
2017 213 Thousand USD 0.0%
2016 - USD 0.0%
2015 - USD -100.0%
2014 4000.00 USD -99.41%
2013 676 Thousand USD -62.94%
2012 1.82 Million USD 11.36%
2011 1.63 Million USD 1389.09%
2010 110 Thousand USD 48.65%
2009 74 Thousand USD -64.93%
2008 211 Thousand USD -89.53%
2007 2.01 Million USD 702.79%
2006 251 Thousand USD -51.73%
2005 520 Thousand USD 0.0%
2003 - USD 0.0%
2002 - USD 0.0%

Peer Long Term Debt Comparison of Sonoma Pharmaceuticals, Inc.

Name Long Term Debt Long Term Debt Difference
Collegium Pharmaceutical, Inc. 489.96 Million USD 99.982%
Embecta Corp. 1.62 Billion USD 99.995%
ANI Pharmaceuticals, Inc. 309.66 Million USD 99.972%
Dynavax Technologies Corporation 252.41 Million USD 99.966%
Esperion Therapeutics, Inc. 501.54 Million USD 99.983%
Pacira BioSciences, Inc. 513.79 Million USD 99.983%
PainReform Ltd. 30 Thousand USD -190.0%
Aquestive Therapeutics, Inc. 91.07 Million USD 99.904%
Sunshine Biopharma, Inc. 539.03 Thousand USD 83.86%
SCYNEXIS, Inc. 12.15 Million USD 99.284%
China SXT Pharmaceuticals, Inc. 117.12 Thousand USD 25.723%
Cosmos Health Inc. 3.03 Million USD 97.134%
Journey Medical Corporation 14.62 Million USD 99.405%
Sunshine Biopharma, Inc. 539.03 Thousand USD 83.86%
Safety Shot Inc 304.9 Thousand USD 71.467%
Alpha Teknova, Inc. 13.25 Million USD 99.343%
Intra-Cellular Therapies, Inc. 13.32 Million USD 99.347%
Bright Green Corporation 201.78 Thousand USD 56.884%
Procaps Group, S.A. 28.41 Million USD 99.694%
Theratechnologies Inc. 51.26 Million USD 99.83%
Harrow Health, Inc. 183.17 Million USD 99.953%
Biofrontera Inc. 804 Thousand USD 89.179%
DURECT Corporation 2.7 Million USD 96.78%
Supernus Pharmaceuticals, Inc. 33.19 Million USD 99.738%
Cronos Group Inc. 1.55 Million USD 94.419%
OptiNose, Inc. 611 Thousand USD 85.761%
Ironwood Pharmaceuticals, Inc. 498.3 Million USD 99.983%
Kala Pharmaceuticals, Inc. 34.19 Million USD 99.746%
RedHill Biopharma Ltd. 455 Thousand USD 80.879%
Organogenesis Holdings Inc. 60.74 Million USD 99.857%
Guardion Health Sciences, Inc. - USD -Infinity%
Cumberland Pharmaceuticals Inc. 12.78 Million USD 99.319%
Radius Health, Inc. 339.66 Million USD 99.974%
Universe Pharmaceuticals INC - USD -Infinity%
ProPhase Labs, Inc. 10.25 Million USD 99.152%
Phibro Animal Health Corporation 458.28 Million USD 99.981%
Procaps Group S.A. 28.41 Million USD 99.694%
Alvotech 1.02 Billion USD 99.992%
TherapeuticsMD, Inc. 6.53 Million USD 98.668%
Viatris Inc. 16.18 Billion USD 99.999%
Rockwell Medical, Inc. 8.29 Million USD 98.951%
Aytu BioPharma, Inc. 10.87 Million USD 99.2%
SIGA Technologies, Inc. 335.99 Thousand USD 74.106%
Tilray Brands, Inc. 287.93 Million USD 99.97%
Lifecore Biomedical, Inc. 120.51 Million USD 99.928%
Shineco, Inc. 10.01 Million USD 99.132%
PetIQ, Inc. 437.82 Million USD 99.98%
Regencell Bioscience Holdings Limited - USD -Infinity%
Incannex Healthcare Limited 210 Thousand USD 58.571%
Neurocrine Biosciences, Inc. 258.3 Million USD 99.966%
Alimera Sciences, Inc. 64.48 Million USD 99.865%
Silver Spike Investment Corp. - USD -Infinity%
Assertio Holdings, Inc. 38.51 Million USD 99.774%
Shuttle Pharmaceuticals Holdings, Inc. 135.08 Thousand USD 35.598%
Petros Pharmaceuticals, Inc. 6.85 Million USD 98.731%
Clever Leaves Holdings Inc. 720 Thousand USD 87.917%
Cyclo Therapeutics, Inc. 22.48 Thousand USD -286.942%
Avadel Pharmaceuticals plc 32.75 Million USD 99.734%
Hempacco Co., Inc. 5.93 Million USD 98.533%
Talphera, Inc. - USD -Infinity%
Alvotech 1.02 Billion USD 99.992%
Eagle Pharmaceuticals, Inc. 56.21 Million USD 99.845%
Lantheus Holdings, Inc. 616.12 Million USD 99.986%
Currenc Group, Inc. 2.5 Million USD 96.53%
Kamada Ltd. 7.43 Million USD 98.83%
Indivior PLC 235.66 Million USD 99.963%
Evoke Pharma, Inc. 5 Million USD 98.26%
Flora Growth Corp. 942 Thousand USD 90.764%
Cyclo Therapeutics, Inc. 22.48 Thousand USD -286.942%
Evolus, Inc. 120.35 Million USD 99.928%
HUTCHMED (China) Limited 48.18 Million USD 99.819%
Amphastar Pharmaceuticals, Inc. 589.19 Million USD 99.985%
Akanda Corp. 2.49 Million USD 96.516%